India CRO Work In Decline, Glenmark, Biocon Looking Elsewhere
This article was originally published in PharmAsia News
Executive Summary
India's clinical-research work has been in steep descent since 2010 and a Supreme Court edict that led to long delays in approval of clinical trials for drugs, including generics.